Metronidazole and its known metabolites in plasma can be rapidly separated by a "high-pressure" liquid-chromatographic method that can also be adapted for rapid determination of tinidazole. Samples deproteinized with trichioroacetic acid (50 g/L final concentration) undergo isocratic separation on a reversed-phase C18 column eluted with an 8/92 (by vol) mixture of acetonitrile/KH2PQ4 (5 mmol/L, pH 3.0). The method is sensitive, reliably detecting as little as 25 .tg of metronidazole and (or) its metabolites per milliliter of plasma. The detector response varied linearly with concentration for all compounds tested over a wide range (25-500 g/L). Within-day and between-day variation was generally less than 2.5% for all concentrations of all compounds tested.
Materials and Methods

Materials.
Metronidazole, its hydroxy metabolite [1-(2-
Tinidazole was purchased from Pfizer Laboratories, Sydney,
Australia.
Preparation of plasma. Heparinized blood specimens from volunteers were centrifuged without delay. The plasma was removed with a Pasteur pipette, stored in aliquots at -20 #{176}C, and thawed just before assay.
We usually placed aliquots of freshly prepared methanolic standards in plastic centrifuge tubes, evaporated the methanol under nitrogen, then added plasma (usually 100 ML) to each tube and mixed thoroughly. For assay of patient's plasma we used tubes that contained only internal standard. A volume of 100 g/L solution of trichloroacetic acid equal to the volume of plasma was added, mixed well, and the mixture was centrifugedfor 2 mm in an Eppendorf bench-top centrifuge. We then injected 10-20 ML of the clear supernatant fluid directly into the chromatograph without prior filtration.
Optimized
HPLC procedure. We used a Model M-6000A HPLC with a single pump and a Model 440 absorbance monitor fitted with a 313-nm wavelength filter kit to monitor column effluent and a newly purchased 3.9 mm x 30 cm reversed-phase Bondapak C18 column (all from Waters Associates Inc., Milford, MA). The mobile phase, a 5 minol/L, pH 3.0 solution of acetonitrile in KH2PO4 (8/92, by vol) was used at a flow rate of 3.4 mL/min. All solvents and chemicals were reagent grade from commercial sourcesand were used without purification.
Results
Optimization Studies
Initially we chose to use the simple solvent system described above, representative of those reported in the literature (9, 10) except that the volume ratio was 4196.
Within the pH range of 2.5-5.0 we had previously determined that pH 3.0 was optimal for peak shape and separation.
As expected, increasing the flow rate from 2.2 to 3.4 mU mm decreased both the retention time of all the imidazoles tested (by about 45%; Figure 2 ) and peak resolution. Within this range, however, the distance between the peaks for metronidazole and the internal standard decreased by less than 20%. We therefore used a flow rate of 3.4 mU/mm for all subsequent experiments. Increasing the acetonitrile concentration from 40 to 80 mLIL shortened analysis time from 12 mm to 6 (Figure 2 ).
The resolution between metronidazole and the internal standard decreased from 7.5 to 6.0 units ( Figure 3 . We found it necessary to eliminate as much protein from the plasma samples as possible. This obviated a guard column and resulted in effluent with less interference and higher reproducibility between runs. Mobile phase, acetonitrile, or methanol all incompletely precipitated plasma proteins at concentrations up to 25 mL of solvent per 75 mL of plasma and produced severely split imidazole peaks at higher concentrations (up to 75 mL/25 mL). Treating plasma with an equal volume of 100 g/L trichioroacetic acid yielded samples that were essentially free of protein and were stable for at least 6 h at room temperature.
Analytical Variables
Precision. Within-day precision studies (n 6 for each concentration of each analyte) showed CVs ranging from 0.7 to 2.5% at 25 g/L for all four imidazole compounds. At greater concentrations(100 and 500 gIL), CVs ranged from 1.4 to 2.5% and from 0.7 to 1.5%, respectively. Between-day precision studies gave similar results, CVs ranging from 1.3% for 500 Mg of the acid metabolite per liter to 4.0% for 25 Mg of the internal standard per liter.
Standard curves. Plots of peak height vs concentration for
all four imidazole compounds are shown in Figure 4 . The highest detector response, that for the acid metabolite, differed significantly from the response for the hydroxy metabolite. Metronidazole, which produces a broader, more slowly eluting peak (Figure 3) , had significantly shorter peaks than its metabolites, whereas the peak heights of the internal standard were less than one-fifth that for an equivalent concentration of acid metabolite. All four imidazole compounds responded linearly over the concentration range tested.
Interference
studies.
We tested several compounds for interference with this assay. Neither bilirubin (10 gIL), gentamicin (10 g/L), aminophylline (10 g/L),nor ampicillin, penicillin, or cephradine (100 mg/L each) interfered with any of the imidazole peaks. While this assay was being developed we were given a serum sample from a female patient who was receiving several drugs concurrently: metronidazole (500 mg per day), diazepam (5 mg per day intravenously), furosemide (250 mg per day intravenously), ampicillin (1 g/6 h), and insulin infusion, (13 mL/h). The resulting trace of this sample (Figure 3) shows that the four imidazole peaks were the only compounds detected. 
Discussion
Our initial attempts to standardize the determination of imidazoles on the basis of one of the reported HPLC methods were frustrated by inconsistent results. This prompted the present study, an attempt to optimize the operating conditions of the assay. Under the conditions selected, one can measure metronidazole, its acid and hydroxy metabolites, an internal standard, and, ifrequired, tinidazole-all within 8 mm of injection. The method is highly reliable, with CVs of <4%, both day-to-day and within-day. Importantly, it does not appear to be adversely affected by the presence of other drugs.
A critical part of this method is the deproteinization step, especially when large numbers of samples are to be analyzed.By preventing minor column contamination, this step allows good chromatographic performance to be maintained. 
Materials and Methods
We obtained 52 serum samples from women receiving 150 mg of clomiphene citrate on days 5-9 of the menstrual cycle for in vitro fertilization. The serum was stored at -20 #{176}C before assay. Immediately after venipuncture, each patient was evaluated with ultrasound (Mark III real-time sector scanner; Advanced Technology Laboratories, Bellevue, WA
98005) as described (2).
The extraction/chromatography method for E2 (1) included an internal recovery standard of 13H117/3-estradiol and
